Biographical summary
Jian L. Campian, M.D., Ph.D., is a Medical Neuro-Oncologist with special interest in early therapeutics development and novel immunotherapeutic combinations to treat brain tumors.
Dr. Campian completed medical oncology and neuro-oncology training at Johns Hopkins University (Baltimore, Maryland). She is a national and international leader in the field of mitigating treatment-related immune suppression and enhancing immune recovery after chemoradiation in cancer patients.
As Principal Investigator or Co-investigator of numerous clinical trials studying primary brain tumors and brain metastases, Dr. Campian leads pioneering translational and clinical research to boost innate immunity and promote immune reconstitution. She is also an innovator in applying chronotherapy-based interventions in cancer patients.
Dr. Campian is board certified by the American Board of Internal Medicine and the American Board of Medical Oncology.
Conditions treated
Procedures performed
Mayo Clinic locations
Education
- 2014
Fellowship - Neuro-OncologyJohns Hopkins Hospital
- 2013
Fellowship - Hematology and Medical OncologyJohns Hopkins Hospital
- 2003
Ph.D.University of Louisville
Activities and honors
Certifications
- 2013
Medical OncologyAmerican Board of Internal Medicine
- 2010
Internal MedicineAmerican Board of Internal Medicine
Awards and honors
- 2021
Top DoctorCastle Connolly
- 2019
Best Doctors in America
- 2016
Siteman Cancer Center Early Phase Clinical Research Support AwardSiteman Cancer Center, Washington University School of Medicine
- 2015
K12 Paul Calabresi Career Development Award for Clinical Oncology Program Paul Calabresi Scholar
- 2013
AACR-Bristol-Myers-Squibb Oncology Fellowship in Clinical Cancer Research AwardAmerican Association for Cancer Research
- 2007
Top 5 Best Posters Award American College of Chest Physicians
- 2006
Young Investigator AwardGordon Research Conference
Professional memberships
- 2021 - present
Society for Neuro-Oncology
- 2020 - present
NCCN
- 2019 - 2021
Brain Tumor Center, Washington University in St Louis/Siteman Cancer Center/Barnes-Jewish Hospital
- 2019 - 2021
National Comprehensive Cancer Network
- 2019 - present
Society for Immunotherapy of Cancer (SITC)
- 2019 - present
Society for Neuro-Oncology
- 2018 - present
Society for Neuro-Oncology
- 2017 - 2021
Washington University Siteman Cancer Center Quality Assurance and Safety Monitoring Committee (QASMC)
- 2017 - present
Washington University ICTS Program
- 2017 - present
American Medical Women's Association
- 2017 - present
Brain Tumor Trials Consortium
- 2015 - present
ALLIANCE for clinical trials in cancer
- 2014 - 2021
Neuro-Oncology Focus Group at Siteman Cancer Center
- 2014 - present
Cancer Immunotherapy Trials Network (CITN)
- 2012 - present
American Association for Cancer Research
- 2012 - present
Society for Neuro-Oncology
- 2012 - present
American Brain Tumor Consortium
- 2010 - present
American Society of Clinical Oncology
Publications
Research activities